Medindia

X

Antibodies in Patients With Rare Disorder may Prevent Type 1 Diabetes and Psoriasis

by Shirley Johanna on  July 18, 2016 at 5:07 PM Research News   - G J E 4
People with a rare autoimmune disorder produce antibodies that may have therapeutic potential for Type 1 diabetes and psoriasis, according to a study conducted on mice.
Antibodies in Patients With Rare Disorder may Prevent Type 1 Diabetes and Psoriasis
Antibodies in Patients With Rare Disorder may Prevent Type 1 Diabetes and Psoriasis
Advertisement

An international team, led by researchers from King's College London, analyzed samples taken from 81 people with a rare autoimmune disorder called autoimmune polyendocrine syndrome type 1 (APECED).

‘The autoantibodies commonly produced by people with autoimmune polyendocrine syndrome type 1 (APECED) was found to inhibit the development of psoriatic pathology.’
Advertisement
To discover if APECED patients' autoantibodies could have therapeutic potential, the team tested them in a mouse model of psoriasis.

They found that injecting the mice with autoantibodies from the APECED patients could inhibit the development of psoriatic pathology.

The team also found that increased T cell auto-reactivity in patients with APECED was linked with increased B-cell auto-reactivity. B cells are a type of immune cell that produces antibodies.

"This is very significant because antibodies make up one of the largest sectors of the pharmaceutical market, and one of the great quests in the pharmaceutical industry is to be able to routinely generate antibodies against human proteins implicated in diseases," said Adrian Hayday from King's College London.

"The findings suggest a route to drug recovery in which, naturally arising highly-efficacious autoantibodies can be isolated from patients whose clinical information guides us as to the diseases most likely to benefit from those antibodies," he added in a paper published in the journal Cell.



Source: IANS
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All